BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9328302)

  • 1. Exhaled nitric oxide and oxygenation abnormalities in hepatic cirrhosis.
    Rolla G; Brussino L; Colagrande P; Dutto L; Polizzi S; Scappaticci E; Bergerone S; Morello M; Marzano A; Martinasso G; Salizzoni M; Bucca C
    Hepatology; 1997 Oct; 26(4):842-7. PubMed ID: 9328302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased excretion of nitric oxide in exhaled air of patients with chronic renal failure.
    Matsumoto A; Hirata Y; Kakoki M; Nagata D; Momomura Si; Sugimoto T; Tagawa H; Omata M
    Clin Sci (Lond); 1999 Jan; 96(1):67-74. PubMed ID: 9857108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of nitric oxide in the exhaled air of patients with chronic glomerulonephritis.
    Kakoki M; Matsumoto A; Nagata D; Kobayakawa N; Kimura K; Momomura S; Hirata Y
    Clin Nephrol; 1999 Aug; 52(2):83-90. PubMed ID: 10480218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis.
    Genesca J; Gonzalez A; Segura R; Catalan R; Marti R; Varela E; Cadelina G; Martinez M; Lopez-Talavera JC; Esteban R; Groszmann RJ; Guardia J
    Am J Gastroenterol; 1999 Jan; 94(1):169-77. PubMed ID: 9934750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolution of gas exchange abnormalities and intrapulmonary shunting following liver transplantation.
    Battaglia SE; Pretto JJ; Irving LB; Jones RM; Angus PW
    Hepatology; 1997 May; 25(5):1228-32. PubMed ID: 9141442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatopulmonary syndrome in liver cirrhosis].
    Culafić Dj; Perisić M; Rebić P
    Srp Arh Celok Lek; 2000; 128(7-8):271-5. PubMed ID: 11089435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating nitric oxide products do not solely reflect nitric oxide release in cirrhosis and portal hypertension.
    Afzelius P; Bazeghi N; Bie P; Bendtsen F; Vestbo J; Møller S
    Liver Int; 2011 Oct; 31(9):1381-7. PubMed ID: 21745317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide production by the alveolar compartment of the lungs in cirrhotic patients.
    Degano B; Mittaine M; Hervé P; Rami J; Kamar N; Suc B; Rivière D; Rostaing L
    Eur Respir J; 2009 Jul; 34(1):138-44. PubMed ID: 19129270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatopulmonary syndrome characteristics in hepatic cirrhosis associated with COPD].
    Nevzorova VA; Pestrikova TL; Kochetkova EA; Osvald M; Doutreleau S; Massard G
    Ter Arkh; 2009; 81(3):15-9. PubMed ID: 19459415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deleterious effect of nitric oxide inhibition in chronic hepatopulmonary syndrome.
    Almeida JA; Riordan SM; Liu J; Galhenage S; Kim R; Bihari D; Wegner EA; Cranney GB; Thomas PS
    Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):341-6. PubMed ID: 17353701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous nitric oxide production is augmented as the severity advances in patients with liver cirrhosis.
    Hori N; Okanoue T; Mori T; Kashima K; Nishimura M; Nanbu A; Yoshimura M; Takahashi H
    Clin Exp Pharmacol Physiol; 1996 Jan; 23(1):30-5. PubMed ID: 8713493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of contrast echocardiography and lung perfusion scan in detecting intrapulmonary vascular dilatation in normoxemic patients with early liver cirrhosis.
    Mimidis KP; Vassilakos PI; Mastorakou AN; Spiropoulos KV; Lambropoulou-Karatza CA; Thomopoulos KC; Tepetes KN; Nikolopoulou VN
    Hepatogastroenterology; 1998; 45(24):2303-7. PubMed ID: 9951913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide in IgA nephropathy patients with or without hypertension.
    Kovács T; Barta J; Kocsis B; Nagy J
    Exp Nephrol; 1995; 3(6):369-72. PubMed ID: 8528682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nebulized N(G)-nitro-L-arginine methyl ester in patients with hepatopulmonary syndrome.
    Gómez FP; Barberà JA; Roca J; Burgos F; Gistau C; Rodríguez-Roisin R
    Hepatology; 2006 May; 43(5):1084-91. PubMed ID: 16628648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatopulmonary syndrome in patients with hypoxic hepatitis.
    Fuhrmann V; Madl C; Mueller C; Holzinger U; Kitzberger R; Funk GC; Schenk P
    Gastroenterology; 2006 Jul; 131(1):69-75. PubMed ID: 16831591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hepatopulmonary syndrome in cirrhosis and extrahepatic portal venous obstruction.
    Gupta D; Vijaya DR; Gupta R; Dhiman RK; Bhargava M; Verma J; Chawla YK
    Am J Gastroenterol; 2001 Dec; 96(12):3395-9. PubMed ID: 11774955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of pulse oximetry screening for hepatopulmonary syndrome.
    Arguedas MR; Singh H; Faulk DK; Fallon MB
    Clin Gastroenterol Hepatol; 2007 Jun; 5(6):749-54. PubMed ID: 17392034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiopulmonary exercise testing and exhaled nitric oxide in the assessment of patients with mitral stenosis.
    Omedè P; Bucca C; Rolla G; Costanzo P; Casoni R; Calachanis M; Morello M; Mangiardi L; Trevi GP
    Minerva Cardioangiol; 2004 Feb; 52(1):29-35. PubMed ID: 14765035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Species-specific modulation of the nitric oxide pathway after acute experimentally induced endotoxemia.
    Bachetti T; Pasini E; Suzuki H; Ferrari R
    Crit Care Med; 2003 May; 31(5):1509-14. PubMed ID: 12771626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
    Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.